Leading US life sciences firm, Mapi, has expanded its footprint in London by locating at Imperial College London’s White City Campus, following an introduction by MedCity. The health research and commercialisation services company is the latest business to join Imperial’s 23-acre research and innovation district, reaffirming The Golden Triangle's position as a global hub for scientific and technological discovery.

Mapi contacted MedCity a number of months ago seeking options for new scientific space for their growing team, and MedCity provided a sense of the available options that could meet their needs and introduced them to the Imperial White City team. FMapi has now moved into the College’s Translation & Innovation Hub (I-HUB), which provides flexible office and lab space for businesses looking to turn cutting-edge research into new products and services.

Mapi is the premier health research and commercialisation company in the life sciences industry, with over 40 years experience of pioneering methodologies to support a more patient-centred approach to healthcare. They help patients, healthcare practitioners and regulators to make treatment decisions based on personal treatment value. Using its global expertise in developing and translating Clinical Outcome Assessments (COA) into practical applications, it generates and communicates real-world evidence on the value of treatments.

Located alongside Imperial research clusters in public health, molecular sciences and biomedical engineering, Mapi’s new home forms part of the wider research and innovation community that Imperial is developing at the White City Campus. By bringing together a network of world-class scientists, engineers and medics, as well as institutional and business partners, the campus will encourage new discussions and collaborations to help turn scientific and medical research into benefits for society.

“Our new White City home will be a global leadership centre for Mapi, allowing our innovative management and operational leaders to tap into the knowledge and dynamism in the UK’s golden triangle of leading universities and entrepreneurs,” commented Mapi’s CEO, James Karis. “The chance to be part of this research ecosystem and the scientific community that calls London home was a key factor in our decision to locate at the I-HUB.”

Dr Eulian Roberts, Chief Executive of Imperial College London ThinkSpace, which operates the I-HUB, said: “Mapi is a fantastic addition to the I-HUB. It is committed to putting the patient at the heart of healthcare research and driving improvements in the way that medical treatment is delivered and experienced.

“Mapi joins a thriving enterprising environment at White City where the sharing of ideas and research will help us to reach new heights not just in medicine, but also in engineering, science and business. Bringing together some of the world’s greatest minds in one place, we’ll be able to leverage their collective knowledge and tackle some of the biggest challenges facing us today.”

White City Campus is already home to a number of leading biotech and scientific research organisations. Earlier this year it was announced that OGCI Climate Investments, a one billion dollar start up focused on advancing low-emission technology, would be the first tenant at Central Working White City – a new collaboration at the I-HUB between Imperial College London ThinkSpace and leading shared workspace provider, Central Working. The I-HUB is also home to a business incubator for lab-based start-up and spin-out companies, such as Polymateria, a company that has developed a fully biodegradable plastic.

If you would like to find out more about how we can help you find a suitable space for your company, get in touch with Phil Jackson, Projects Director, at philjackson@medcityhq.com or +44 (0)20 3179 8102

About Mapi

Mapi Group has over 40 years of experience supporting Life-Science companies in developing and implementing strategies for commercializing novel treatments through Real-World Evidence, Strategic Regulatory Services, Pharmacovigilance,  Market Access, Language Services. Mapi Group is the premier provider of Health Research and Commercialization services to Life-Science companies enabling Market Authorization, Market Access and Market Adoption of novel therapeutics.  Visit http://www.mapigroup.com for more information.

About the White City Campus

Imperial College London is developing its newest campus across 23 acres adjacent to White City station in West London.  As it evolves, it will become a centre of discovery and innovation, supporting the College’s mission to achieve enduring excellence in research and education in science, engineering, medicine and business for the benefit of society. The campus will further enable co-location and collaboration between students, academics, businesses, entrepreneurs and the local community.

In close proximity to Hammersmith Hospital, the northern section of the White City Campus will focus on multidisciplinary research in health and wellbeing.  Academic hubs will foster research in molecular sciences, biomedical engineering and public health:

  • The Molecular Sciences Research Hub will be a new home for research from Imperial’s Department of Chemistry.  The facility will encourage pioneering collaboration between scientists, engineers and clinicians from different disciplines and institutions.
  • The Michael Uren Biomedical Engineering Research Hub will bring together engineers, scientists and medical researchers to collaborate on new medical technology. This ambition has been made possible by a £40 million donation from Imperial alumnus Michael Uren OBE and the Michael Uren Foundation, the largest donation in the College’s history.
  • The I-HUB provides a space for corporate partners, fast-growth and start-up companies to work side-by-side with Imperial academics in modern wet-labs and flexible incubators to translate the outcomes of research into commercial applications.
  • The northern section of the campus also provides graduate student accommodation at Wood Lane Studios and will soon be home to a new residential tower (including apartments at below market rent for Imperial key worker staff).

Master-planning is underway for the southern site which will include new spaces for multidisciplinary academic research, accommodation for commercial and research partners and public areas for people to meet, mix and engage with Imperial’s work.